Post-Intensive Care Syndrome Intensive Care Medicine E43 E44 R64 M62.5 G62.80 G72.80
Conditions
Interventions
Group 1: Telemedical implementation of the nutritional assessment and management of nutritional therapy in accordance with guidelines and the clinic's internal standard operating procedure (SOP)
Group
Sponsors
Klinik für Anästhesiologie und Intensivmedizin (CCM/CVK), Charité - Universitätsmedizin Berlin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Age = 18 years - previous intensive care length of stay <72h - expected duration of treatment = 72h - indication for enteral or parenteral nutrition - non-consenting patients who are included via a caregiver/spouse representative/authorized representative until study day 14 and subsequently consent themselves until hospital discharge - patients capable of giving consent who consent before the start of the intervention
Exclusion criteria
Exclusion criteria: - refusal to participate in the study - parallel participation in a prospective intervention study (unless parallel inclusion was permitted by the study management)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patient days (%) until day 14 or ICU discharge on which the target calorie intake was achieved. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measures of care (up to day 14 or ICU discharge unless otherwise stated): 1. rate in patient days on which target protein intake was achieved 2. rate of days with adherence to the nutrition plan (yes/no) 3. composition of the food administered (macro- and micronutrients according to documentation) 4. duration of the telemedical visit. 5. rate in patient days with enteral or parenteral, as well as supportive parenteral nutrition 6. daily nutritional breaks in hours 7. daily mean blood glucose 8. daily blood glucose variability 9. rate in patient days on which glucose target range was achieved 10. daily insulin requirement IU/kg/h) Secondary endpoints (until day 14 or ITS discharge unless otherwise stated): 1. number of instrumental examinations (indirect calorimetry, bioimpedance analysis, hand grip measurement) standardized to observation days 2. medical research council (MRC) score (at study inclusion, day 14 or ITS discharge) 3. hand grip measurements (at study inclusion, day 14 or ITS discharge) 4. intensive care mobility scale (at study inclusion, day 14 or ITS discharge) 5. functional independence test (FIM) score (at study inclusion, day 14 or ITS discharge) 6. delirium incidence in the intensive care unit 7. delirium-free days in the intensive care unit 8. delirium severity in ICU measured with the Intensive Care Delirium Screening Checklist (ICDSC) (in ICU every 8 hours, according to SOP) 9. depth of sedation: Richmond Agitation Sedation Scale (RASS) (on ITS every 8 hours, according to SOP) 10. analgesia level: Numerical Rating Scale Visualized (NRS-V) or Faces Pain Scale Revised (FAS-R) Behavioural Pain Scale (BPS) or Behavioural Pain Scale for non-intubated patients (BPS-NI) (on ITS every 8 hours, according to SOP) 11. total amount of opioids administered per ITS treatment day 12. total amount of sedatives administered per ITS treatment day 13. occurrence of sepsis/septic shock 14. sequential organ failure assessment (S | — |
Countries
Germany
Contacts
Public ContactBjörn Weiß
Klinik für Anästhesiologie und Intensivmedizin (CCM/CVK), Charité - Universitätsmedizin Berlin
Outcome results
None listed